Argonautica Private Wealth Management, Inc Gilead Sciences, Inc. Transaction History
Argonautica Private Wealth Management, Inc
- $291 Billion
- Q1 2025
A detailed history of Argonautica Private Wealth Management, Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Argonautica Private Wealth Management, Inc holds 3,856 shares of GILD stock, worth $420,651. This represents 0.15% of its overall portfolio holdings.
Number of Shares
3,856
Previous 4,109
6.16%
Holding current value
$420,651
Previous $380 Million
13.84%
% of portfolio
0.15%
Previous 0.12%
Shares
10 transactions
Others Institutions Holding GILD
# of Institutions
2,285Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.8 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.49 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.96 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.84 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $137B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...